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Abstract
The increased incidences of Healthcare-associated Infections (HAI) caused by multidrug-resistant 
bacteria, have led to an enlarged number of morbidity and mortality cases. Besides, other factors 
that are affected are patients, families and institutions providing health services. Therefore, the 
permanent study of the subject is necessary to identify possible strategies that contribute to the 
reduction of the issue. A critical review of the literature based on the origin of antibiotics, the 
evolution of their respective resistance, and the impact on public health from a historical and 
current perspective was developed. The search of the literature was carried out in the bibliogra-
phic databases: Pubmed, Web of Science, Scopus, SciELO, The Cochrane Library and Lilacs. 
The reviewed literature showed, from the historical viewpoint, the discovery of antibiotics to 
the last-generation antibiotics. The rapid coevolution of genes for antibiotics resistance and its 
subsequent spread to hundreds of species of microorganisms by Horizontal Transfer gene (HTG) 
was also reviewed. It is also discussed how the expansion in antimicrobial resistance (AMR) 
generates a series of factors that increase health-care associated infections care (HAI) and their 
impact on public health. The development of antibiotics from the discovery to recent changes 
in the behavior and response of the microorganisms with the generation of AMR shortly after, 
is one of the most fantastic examples of the evolution that exists in nature.
Key words: Microbial Drug Resistance, Bacterial Genes, Infection, Horizontal Gene 
Transfer, History.
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Resumen
El aumento en la incidencia de infecciones asociadas a la atención en salud causada por mi-
croorganismos multiresistentes a antibióticos, han incrementado la morbilidad, mortalidad 
y otros factores que afectan a paciente, familias e instituciones prestadoras de servicios de 
salud; por lo que se ha hecho necesario el estudio permanente del tema, para identificar posibles 
estrategias que contribuyan a disminuir la situación. Se realizó una revisión de la literatura 
sobre el origen de los antibióticos, la evolución de su respectiva resistencia, el impacto en la 
salud pública; desde una perspectiva histórica y actual. La búsqueda de la literatura se realizó 
en las bases de datos bibliográficas: Pubmed, Web of Science, Scopus, SciELO, The Cochra-
ne Library y Lilacs. El análisis de la literatura mostró desde el punto de vista histórico, el 
descubrimiento de los antibióticos hasta los últimos antibióticos de última generación, y la 
rápida coevolución de los genes de resistencia a los antibióticos y su posterior diseminación 
a cientos de especies de microorganismos mediante la Transferencia Horizontal de Genes 
(THG). También es discutido como el incremento de la resistencia a los antibióticos (RAM) 
genera una serie de factores que potencian las infecciones asocia de las a los cuidados de la 
salud (IACS) y su impacto en la salud pública. La historia desde el descubrimiento, los cam-
bios en el comportamiento de uso de los antibióticos y la respuesta de los microorganismos 
con la generación de la RAM poco tiempo después, es uno de los ejemplos más fantásticos de 
coevolución que existe en la naturaleza.
Keywords: Resistencia microbiana a los medicamentos, genes bacterianos, infección, 
Transferencia horizontal de genes, Historia.
INTRODUCTION
Since the beginning of the antibiotics era, the 
resistance to these substances has described, 
during several decades; antimicrobial resistance 
(AMR) has been an increasing menace for the 
effective treatment of a wide range of infections 
caused by bacteria, parasites, virus and fungi. 
AMR produces a reduced efficacy of antibacte-
rials, antiparasitics, antivirals and antifungals; 
turning difficult the treatment of patients who 
have got this kind of microorganisms (1). The ori-
gin, evolution and resistance mechanisms have 
appeared during the last 60 years; at the begin-
ning, the problem was solved with the synthesis 
of new substances which were capable to control 
bacteria with AMR, then other medicaments 
appeared such as aminoglycosides, macrolides, 
glycopeptides, among others (2). During the first 
world congress about antibiotics resistance, the 
World Health Organization (WHO)) exposed 
that the so called “killer bacteria” are a world-
wide menace, with a great ability to mutate; 
even avoiding broad-spectrum antibiotics, 
in the same way the data of 114 countries 
previously analyzed and it was also exposed 
that AMR is currently present worldwide 
and at every social level (3). The alarming 
increase of AMR is, without a doubt, one of 
the biggest problems of current public health, 
since these compounds are one of the main 
tools to control and treat bacterial infections, 
in human medicine as well as in veterinary.
Recent studies estimated the economical 
effects of ARM, for example; the annual cost 
for health system in USA is estimated from 
21 to 34 billion dollars, accompanied by 
more than 8 million days in hospital (4); in 
Europe, it is estimated a cost around €1.600-
6.000 per year in patients with resistance 
to third-generation cephalosporines (5); a 
study made in 12 European countries (Bel-
gium, France, Germany, Italy, Netherlands, 
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Poland, Slovakia, Slovenia, Spain, Sweden and 
the United Kingdom) evaluated the costs of 
medical attention and the resistance to multi-
ple medicines finding that this amounted to € 
727.4 135 (£ 589 856) (6); the costs in Singapore 
are around USD$ 8638.58 in multiresistant in-
fections (7); in Spain, the average economical 
cost per admission of patients who have got 
strains resistant to multiple medicines is higher 
than the ones with non-resistant strains with 
€15.265 compared to €4.933 for the others (8); 
in South Africa, the average cost of a successful 
tuberculosis treatment in patients resistant to 
rifampicin was USD $8359 (9). Therefore, the 
objective of this study was to make a critical 
review of the literature about the evolution 
of AMR, from different perspectives: Histo-
rical, molecular, mechanisms and its impact 
in public health.
MeThODOlOgy
A thorough review about the origin and impact 
of antibiotics and their endurance regarding 
the infections associated with health assistance 
worldwide was made with a historical and 
current perspective. This review is the result 
of the execution of the research project entit-
led: “Molecular typing of resistance genes in 
gram-negative bacilli associated to infections 
in a health service provider institution in 
Boyacá”. For the identification of the studies, 
the bibliographic databases consulted were; 
Pubmed; Web of Science; Scopus; SciELO; 
The Cochrane Library and Lilacs. It was set a 
deadline for publications from 2010 to 2017. 
They were considered original researches or 
review articles, available in English or Spanish. 
Key words validated in Descriptors in Health 
Sciences were also used, which included mi-
crobial resistance to drugs, bacterial genes, 
infection, horizontal gene transfer and history.
ResUlTs
Evolution of AMR
Since the emergence of humankind, the use 
of natural resources ha sbeen sought for its 
benefit, as an adaptive strategy to different 
environments.Several natural products were 
used by observation or intuition, in order to 
improve their health and welfare, mainly, fa-
cing the presence of pathogenic agents.Once 
these resources were considered exhausted 
and measured by advances in science, they 
resorted to chemical synthesis (10).
AMR has been described since the beginning 
of the 30s. After the use of penicillin in World 
War I, the first resistant bacteria emerged; 
in 1945, Fleming postulated the potential 
risks associated to the use of antibiotics; he 
showed that the use of a large and prolonged 
scale can select resistant bacteria, observing 
in his laboratory that bacteria sensitive to pe-
nicillin multiply in the presence of increasing 
concentrations of the antibiotic (11). During 
the 40s, the first report of penicillin resistan-
ce by strains of Escherichia coli (E. coli) and 
Staphylococcus sp was reported (12). In 1947, 
resistance to streptomycin among patients 
with tuberculosis was detected, where 80% 
of them relapsed within three months due 
to the formation of resistant bacilli (13). In 
the years 1952 and 1957, resistance to tetra-
cycline and chloramphenicol was reported 
and in the decade of the 60s, β-lactamases 
producing strains, such as TEM and SHV of 
wide spectrum (detected in gram-negative 
bacilli) were discovered (14) (15).
Extended-spectrum β-lactamases (ESBLs) 
are phenotypically resistant to penicillins 
and cephalosporins; they were registered for 
the first time in E. coli in 1964 (16). Later, in 
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the 80s, antibiotics such as aminoglycosides 
(including vancomycin) were detected from 
resistant strains of Enterococcus; a short time 
later, it was found resistance to ampicillin in 
different species and the list kept growing (17). 
At the end of the 70s, bacteria resistant to am-
picillin and cephalosporins were reported (12). 
In 1980, it was estimated that between 3-5% 
of Streptococcus pneumoniae (S. pneumoniae) 
was resistant to penicillin; but in 1998, 34% of 
these bacteria increased their resistance to this 
antibiotic. In the same decade, resistance to 
vancomycin and erythromycin was observed 
(13). Subsequently, in 1999 the multiresistance 
of gram-negative bacteria was described. For 
the period from 2002 to 2009, an increase in 
strains of E. coli resistant to broad-spectrum 
cephalosporins was observed, which is pre-
sent in most of European countries. In 2008, 
a new enzyme called “New Delhi Metallobe-
talactamase” was observed, which confers 
resistance to all beta-lactam antibiotics, except 
aztreonam; showing a global alert against 
AMR to several non-beta-lactam antibiotics 
(18), leaving a few therapeutic options for 
the treatment of patients infected with these 
bacteria. After this report, the presence of 
this type of resistance was identified in 2010 
in Canada, in 2011 in the United States and 
Guatemala; in 2012 in Uruguay, Paraguay 
and Colombia (19).
AMR is one of the most spectacular and docu-
mented natural event in microbial evolution, 
from the origin and application of antibiotics, 
passing through a few years in order to make 
that the different phenotypes arise; twelve 
years after the origin and application of pe-
nicillin, the first resistance mechanism was 
detected (20). This is how it is observed that, 
in a few years, bacteria can increase the speed 
of AMR generation. For example, in ten years 
after having resistant strains to penicillin and 
methicillin, resistance to chloramphenicol 
emerged, and in four years to streptomycin. 
Therefore, AMR is a growing public health 
problem, seen barely some years after the 
discovery of penicillin (21). That is why, a 
question arises from the emergence of AMR: 
What is or what are the mechanisms involved 
in this fast production of AMR?
Origin of AMR
Throughout the five decades that followed the 
synthesis and the indiscriminate use of anti-
biotics in people, animals and agriculture; a 
selective process unprecedented in the history 
of evolution has been observed, due to the fact 
that it has been an unregulated practice that 
lacks control and supervision (22); but this 
selection, considered by many researchers as 
artificial, has many components to consider 
in this review; in addition to the selective 
effect, the high rate of mutations in bacteria, 
the formation of bacterial communities and 
the horizontal transfer of genes, are impor-
tant factors in the generation of AMR (23). 
There are several examples in the literature 
of spontaneous mutations in bacteria; some 
researchers consider that the evolution of resis-
tance, through the acquisition of spontaneous 
mutations is particularly relevant for certain 
drugs, such as quinolones and rifamycins, 
for which the high-level resistance can result 
from a point mutation (22, 24). For example, in 
Salmonella typhimurium (S. typhimuriun), with 
a point mutation in the henC gene, the resis-
tance of the bacteria to protamine increases, 
but with a cost in the reduction in bacterial 
growth (25); similar results were described 
in Salmonella enterica, where mutations in 
the tRNA-isoleucine gene confer resistance 
to mupirocin but with a reduction in growth 
(26). Other authors consider that AMR can 
evolve through the accumulation of multiple 
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sequential mutations and not by single point 
mutations (27); this mechanism would be 
responsible of the high levels of AMR that 
currently present many of the microorganism 
species, pathogenic species(28). These results, 
have shown that microorganisms that have a 
strong selective pressure (high concentrations 
of antibiotics), have RAM in a short period; 
similar to the one presented currently, es-
pecially in treatments against infections in 
humans (29).
It is presumed that there exist around 20 thou-
sand resistant genes, predicted through the 
analysis of DNA sequences of different bacte-
rial genomes however, they are functionally 
expressed in just some of them (28); many of 
them are originated by unique or consecutive 
punctual mutations, or also by gen duplica-
tions. But, what is the reason for these genes 
to be distributed in other strains or bacterial 
species presented in different environments? 
The answer to this question can be found in 
studies of comparative genomics. The iden-
tification of the sequences of bacterial genes 
in eukaryotic genomes, as the presence and 
genomics of pathogenicity islands presented 
in E.coli, found in other animal pathogenic, in 
human genome and some plant species; they 
confirm the theory of horizontal gene transfer 
(30). Horizontal gene transfer (HGT) has been 
considered as the mechanism responsible of 
the dissemination of antimicrobial resistance 
genes through different bacterial species (31). 
Actually, the genes that present resistance to 
certain antibiotics in non-related phylogene-
tically bacteria, demonstrate to have iden-
tical nucleotide sequences, including Gram 
positive and negative bacteria; it emerged at 
the beginning of the decade of 1990; it was a 
way to explain the phylogenetic incongruence 
using different gene trees. This process can also 
occur among the domains in all the possible 
directions, from bacteria to archaea, bringing 
new data about the rise of the genomic era, 
which has permitted the comparison of genes 
among different species (32). The interchange 
of genetic material in HGT among genomes 
is carried in different ways, acquiring a great 
relevance in the prokaryotic evolution due to 
the resistance to antibiotics that contribute to 
the inclusion of new mechanisms by bacteria 
(33, 34). 
HGT is a phenomenon which takes place in 
and within the three domains of life (Fig. 1). 
The acquisition of genes by bacteria has got 
accelerated by the increase of adaptive and 
selective pressure needs, specifically the use 
of antibiotics in infections control in medicine, 
veterinary, agriculture and animal nutrition 
(35); the mark of the transference corresponds 
to the existence of a gene or genic sequence in 
the phylogenetic tree of the organism and to 
the observation of the same genic disposition 
in the donor and receptor bacterial population 
(31, 36). 
With the recent increase of the studies in me-
tagenomics, in which resistance to antibiotics 
has been identified in different ecosystems 
(37), for example; in human micro biome 
which generated complete genome sequences 
of several hundreds of human microbes, it has 
confirmed this HGT theory. Liu et al, detected 
a total of 13.514 genes coming from HGT 
identified in 308 human microbes in different 
parts of the body (including intestine, mouth, 
skin, etc.), with an average of 43,9 HGT per 
microbe THG (30). Besides this finding, resear-
chers discuss the possibility of THG among 
the micro biome and the cells of our body; 
and how this event can be related to human 
health due to the fact that the total number of 
microbial cells hosted by the human body is 
10 times greater than the number of human 
499Salud Uninorte. Barranquilla (Col.) 2018; 34 (2): 494-505
Antibiotic Resistance: Origins, evolution and healthcare-associated infections
cells in the body (100 times the number of 
genes in the human genome); The theory of 
HGT between the microbiome and the cells 
of our body is more than supported, but this 
behavior is not exclusive of the human mi-
crobiome (38). 
The acquisition of genes by bacteria is accele-
rated, increasing the need of adaptation and 
selective pressure, specifically, by the use of 
antibiotics to control infections in human 
medicine, veterinary medicine and agricul-
ture. Therefore, being in permanent contact 
with diverse environments, farm or domestic 
animals, plants, insects, among others HGT 
could be present even more frequently than 
it is commonly thought (31, 39)
Among the most probable mechanisms of 
HGT are conjugation, transformation and 
transduction; in which mobiñe genetic mole-
cules take part such as plasmids, bacteriopha-
ges, transposons, integrons and gene cassettes 
that have genes with functions for their own 
transfer and / or bacterial resistance (40). In 
chat 1 examples can be found of mobile ge-
netic elements that transfer resistance genes.
One of the most common and known mecha-
nism is the conjugation by means of plasmid 
transfer, taking resistance genes; in Gram-
negative bacteria, resistance genes are found 
as a part of small mobile genetic elements or 
“cassettes”, integrated in greater elements 
(integrons) (41). Integrons are structures of 
interest because they are found in the bacte-
rial chromosome structure presented in the 
cassettes of genes related to resistance; it has 
been observed that more than a cassette can 
be inserted in the same integron to generate 
molds that contribute to the spreading of the 
multiple resistance (42). Resistance genes 
spreading is higher when these are part of 
mobile genetic cassettes, which permit them 
to be transferred by several mechanisms (43). 
There exists enough scientific evidence of 
the high rate of HGT among gram-negative 
and positive bacteria, generated mainly by 
conjugation.
Cassettes can codify several compounds that 
generate resistance for a huge range of anti-
biotics including ß-lactam, aminoglycosides, 
trimethroprim, amphenicol, sulfonamide, 
tetracyclines, rifampicin, erytromycin and 
quinolones (44).Therefore, integrons and cas-
settes that bring multiple ARM are, currently, 
the most studied genic elements by researchers 
in order to explain the origin of ARM and its 
impact in public health. 
AMR in health-care associated infections
During more than 60 years, antibiotics have 
been considered as the panacea to cure in-
fections, with enormous benefits for human 
health. The development of the resistance to 
this important class of medicaments, and the 
consequent loss of its efficacy as an antimi-
crobial therapy, represents a serious health 
menace. Despite the efforts of hospitals to 
improve the caring process and health of the 
patient, infections still occur with a higher 
frequency; it has been complex to determine 
the world range exactly; it is estimated that 
every year billions of patients get affected 
(45). Health-care associated infections (HAI) 
are defined as any infectious process, general 
or localized, that occurs due to the stay or 
attendance to a health center and appears 
during or after the discharge more than 48 
hours after the entry. They include blood 
infections, affected area by a surgery, skin 
and soft tissue, pneumonia, and urinary tract 
infections which are the most common (46). 
Therefore, HAI, besides entailing an adverse 
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effect for the patient, are also an indicator of 
the caring quality. The rise and reemergence of 
HAI, caused by ARM microorganisms, has as 
a consequence the increase of morbidity and 
mortality in hospitals around the world (47, 
48). They are associated to economic effects in 
institutions, in health systems and therefore 
in economical ranges for the countries (49-51).
In the American continent, a prevalence of 
HAI is present which varies from 4.5% in 
the United States, to 14% in Brazil (52). Other 
studies in several countries of America reveal 
a wide variation in the incidence of resis-
tance in common bacterial pathogens, as an 
example, the resistance to third generation 
cephalosporines observed in E. coli, varying 
from 0% in the case of Brazil to 50% in Peru; 
in comparison with the world reports where 
they are found in 26.8% (53).
The increase of the resistance has become one 
of the most important aspects in the world 
and this is why, the antimicrobial resistance 
was declared as a public health problem by 
the World Health Organization in 1999; it is 
related to the excessive and indiscriminate use 
of antibiotics in the community and hospitals, 
as a decisive factor in the origin of the rise of 
resistant pathogens nowadays (3).Therefore, 
it is necessary to promote strategies of control 
of AMR through the exact identification of the 
microorganism and its resistance phenotype, 
besides the opportune information of these 
results to the service of infectious disease 
treatment in the hospital, in order to avoid 
the proliferation of multiresistant strains that 
produce new HAI (46).
CONClUsIONs
The history of the discovery and usage of 
antibiotics and their corresponding ARM 
generation a short time later, is one of the 
most fantastic examples of coevolution that 
exist in nature. One of the decisive factors in 
this case is the indiscriminate use of antibio-
tics at different levels: In human, animal and 
environmental medicine. The last mentioned, 
can emerge when the antibiotics that were not 
consumed are thrown, taking the risk of gene-
rating resistant bacteria in the environment.
On the other hand, the rise of resistance 
genes can have several origins: (a) Punctual 
mutations, (b) Consecutive mutations of high 
frequency and, (c) genic duplications. Besides, 
microorganisms are held to strong selective 
pressures, due to the indiscriminate use of 
antibiotics which cause multiresistant strains. 
In the same way, these ARM microorganisms 
are able to transfer their resistant genic pool to 
other strains or sensitive species to antibiotics 
by different HGT mechanisms as transduction, 
transformation and conjugation. HGT can 
be presented in different auspicious envi-
ronments as health attention centers where 
different types of infections are treated and 
their different origins increasing the HGT 
potential. The increase of HAI is originated for 
multiple factors, most of them, avoidable. Un-
fortunately, in many HGT cases, infections are 
originated by multiresistant microorganisms, 
even to last generation antibiotics, increasing 
the morbidity and mortality around the world.
In a consistent way with the alarms of the 
WHO, the studies related to ARM must be 
increased as well the respective restrictions 
of antibiotics usage, mainly in developing 
countries as the ones of South-America.
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Las HSPs tienen 4 regiones funcionales conservadas. En Azul claro dominio N-terminal (llamado dominio J), En azul 
la región flexible rica en glicina/fenilalanina, en verde la región M de unión al sustrato y en rojo la región N-terminal. 
Fuente: Realizada por los autores de la revisión.
Figure 1. The horizontal transfer of genes between the domains of life
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